Syrians split over government readmission into Arab League

BEIRUT/DAMASCUS (Reuters) – Syrian factions have given mixed reactions to an Arab League decision to lift the suspension on Syria’s membership after more than a decade of isolation, underscoring the deep rifts cut into the country by years of bloodshed. The decision on Sunday by foreign ministers of Arab League countries consolidates a regional push…

Read More

After weight loss, Alzheimer’s may be next frontier for drugs like Ozempic

By Natalie Grover LONDON (Reuters) – Diabetes drugs that also promote weight loss such as Novo Nordisk’s Ozempic, becoming a darling of celebrities and investors, are being studied to tackle some of the most difficult-to-treat brain disorders, including Alzheimer’s disease. Diabetes regimens, from Ozempic to old mainstays like insulin and metformin, appear to address several…

Read More